title: Indices of activity of the nitric oxide system in hemodialysis patients.
abstract: Arginine deficiency and/or increased levels of circulating nitric oxide (NO) synthesis (NOS) inhibitors can cause reduced NOS, which may contribute to hypertension in patients with end-stage renal disease (ESRD). To test these hypotheses, NO oxidation products (NO(2) + NO(3) = NO(x)) and cyclic guanosine monophosphate (cGMP), the vasodilatory second messenger of NO, were measured in the blood, urine, and dialysate effluent of hemodialysis (HD) patients and compared with the blood and urine of healthy subjects. The subjects ate a controlled low-nitrate diet (approximately 330 micromol/d) for 48 hours before and during blood, dialysis effluent, and 24-hour urine collection. NO(x) output was significantly reduced in HD patients versus controls (552 +/- 51 v 824 +/- 96 micromol/24 h; P < 0.001), whereas cGMP output was not low versus controls. Plasma arginine level was normal and plasma levels of citrulline and the endogenous NOS inhibitor, asymmetric dimethylarginine (ADMA), were markedly elevated in patients with ESRD versus controls. Systolic blood pressure was greater in HD patients compared with controls despite concurrent antihypertensive therapy in most patients with ESRD. These studies suggest NO production is low in patients with ESRD undergoing HD, possibly because of the increased ratio of plasma ADMA to arginine.
authors.affiliation: Basic Pharmaceutical Sciences, West Virginia University, Morgantown, WV, USA. cbaylis@wvu.edu
authors.forename: R J
authors.initials: RJ
authors.lastname: Schmidt
authors.forename: J
authors.initials: J
authors.lastname: Domico
authors.forename: L S
authors.initials: LS
authors.lastname: Samsell
authors.forename: S
authors.initials: S
authors.lastname: Yokota
authors.forename: T S
authors.initials: TS
authors.lastname: Tracy
authors.forename: M I
authors.initials: MI
authors.lastname: Sorkin
authors.forename: K
authors.initials: K
authors.lastname: Engels
authors.forename: C
authors.initials: C
authors.lastname: Baylis
mesh_terms: D001120:Arginine / Q000031:analogs & derivatives / Q000097:blood; D001794:Blood Pressure; D002956:Citrulline / Q000097:blood; D006152:Cyclic GMP / Q000378:metabolism; D004032:Diet; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009566:Nitrates / Q000008:administration & dosage; D009569:Nitric Oxide / Q000097:blood*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D006435:Renal Dialysis; D015290:Second Messenger Systems
chemical_list: D009566:Nitrates; D002956:Citrulline; D009569:Nitric Oxide; D001120:Arginine; D019001:Nitric Oxide Synthase; D006152:Cyclic GMP